Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-26T16:45:55.028Z Has data issue: false hasContentIssue false
  • English
  • Français

Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds

Published online by Cambridge University Press:  29 January 2008

G. Bedi  and
J. Redman
G. Bedi*
Affiliation:
Department of Psychology, Monash University, Melbourne, Australia
J. Redman
Affiliation:
Department of Psychology, Monash University, Melbourne, Australia
*
*Address for correspondence: G. Bedi, D.Psych., Human Behavioral Pharmacology Laboratory, Department of Psychiatry, University of Chicago, 5841 S. Maryland Ave., MC 3077, Chicago, IL 60637, USA. (Email: gbedi@bsd.uchicago.edu)
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Although there have been several reports linking ecstasy use with lowered cognitive function, much previous research suffers from substantial methodological limitations. The present study aimed to examine associations between ecstasy use and higher-level cognitive functions, using a larger sample size than most previous research and better controlling for a range of potential confounds.

Method

A cross-sectional cohort design assessed 45 currently abstinent ecstasy polydrug users (EP), 48 cannabis polydrug users (CP) and 40 legal drug users (LD). Standardized neuropsychological tests were used to measure attention, verbal, visual and working memory and executive function. Prospective memory function was also assessed.

Results

It was not possible to discriminate between groups on the basis of the cognitive functions assessed. Regression analyses showed an inverse association between lifetime dose of ecstasy and verbal memory performance. A combination of drug-use variables, including measures of ecstasy use, contributed to prediction of attention/working memory. However, individual associations were small, explaining 1–6% of variance in cognitive scores.

Conclusions

Although the results suggest that heavy use of ecstasy is associated with some lowering of higher-level cognitive functions, they do not indicate a clinical picture of substantial cognitive dysfunction.

Keywords

Cannabiscognitionecstasymemorypolydrug
Type
Original Articles
Information
Psychological Medicine , Volume 38 , Issue 9 , September 2008 , pp. 1319 - 1330
Copyright
Copyright © 2008 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Allott, K, Redman, J (2007). Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)? Neuroscience and Biobehavioral Reviews 31, 327–347.CrossRefGoogle Scholar
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn.American Psychiatric Press: Washington, DC.Google Scholar
Australian Crime Commission (2005). Illicit Drug Data Report 2003–2004. Australian Crime Commission: Canberra, Australia.Google Scholar
Back-Madruga, C, Boone, KB, Chang, L, Grob, CS, Lee, A, Nations, H, Poland, RE (2003). Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. Clinical Neuropsychologist 17, 446–459.CrossRefGoogle Scholar
Battaglia, G, Yeh, SY, De Souza, EB (1988). MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacology, Biochemistry and Behavior 29, 269–274.CrossRefGoogle ScholarPubMed
Beck, AT, Steer, RA (1993). Beck Anxiety Inventory Manual. The Psychological Corporation: San Antonio, TX.Google Scholar
Bedi, G, Redman, J (2006). Self-reported ecstasy use: the impact of assessment method on dosage estimates in recreational users. Journal of Psychopharmacology 20, 432–436.CrossRefGoogle ScholarPubMed
Bedi, G, Redman, J (in press). Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean? Journal of Psychopharmacology.Google Scholar
Bhattachary, S, Powell, JH (2001). Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or ‘ecstasy’: evidence for cognitive impairment. Psychological Medicine 31, 647–658.CrossRefGoogle ScholarPubMed
Bolla, KI, McCann, UD, Ricaurte, GA (1998). Memory impairment in abstinent MDMA (‘Ecstasy’) users. Neurology 51, 1532–1537.CrossRefGoogle ScholarPubMed
Clemens, KJ, Cornish, JL, Li, KM, Hunt, GE, McGregor, IS (2005). MDMA (‘Ecstasy’) and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. Neuropharmacology 49, 195–207.CrossRefGoogle ScholarPubMed
Cole, JC, Sumnall, HR, Grob, CS (2002). Sorted: ecstasy facts and fiction. Psychologist 15, 464–467.Google Scholar
Croft, RJ, Mackay, AJ, Mills, ATD, Gruzelier, JGH (2001). The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153, 373–379.CrossRefGoogle ScholarPubMed
Eaton, WW, Smith, C, Ybarra, M, Muntaner, C, Tien, A (2004). Center for Epidemiologic Studies Depression Scale: review and revision (CESD and CESD-R). In The Use of Psychological Testing for Treatment Planning and Outcomes Assessment: Vol. 3: Instruments for Adults (ed. Maruish, M. E.), pp. 363–377. Lawrence Erlbaum Associates: Mahwah, NJ.Google Scholar
Fox, HC, McLean, A, Turner, JJD, Parrott, AC, Rogers, R, Sahakian, BJ (2002). Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (‘ecstasy’) polydrug users. Psychopharmacology 162, 203–214.CrossRefGoogle ScholarPubMed
Fox, HC, Toplis, AS, Turner, JJD, Parrott, AC (2001). Auditory verbal learning in drug-free ecstasy polydrug users. Human Psychopharmacology: Clinical and Experimental 16, 613–618.CrossRefGoogle ScholarPubMed
Giancola, PR, Tarter, RE (1999). Executive cognitive functioning and risk for substance abuse. Psychological Science 10, 203–205.CrossRefGoogle Scholar
Gouzoulis-Mayfrank, E, Daumann, J, Tuchtenhagen, F, Pelz, S, Becker, S, Kunert, HJ, Fimm, B, Sass, H (2000). Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). Journal of Neurology, Neurosurgery and Psychiatry 68, 719–725.CrossRefGoogle ScholarPubMed
Gouzoulis-Mayfrank, E, Fischermann, T, Rezk, M, Thimm, B, Hensen, G, Daumann, J (2005), Memory in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use. Drug and Alcohol Dependence 78, 317–323.CrossRefGoogle ScholarPubMed
Gouzoulis-Mayfrank, E, Thimm, B, Rezk, M, Hensen, G, Daumann, J (2003). Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Progress in Neuro-Psychopharmacology and Biological Psychiatry 27, 819–827.CrossRefGoogle ScholarPubMed
Gravetter, FJ, Wallnau, LB (2004). Statistics for the Behavioral Sciences, 6th edn.Wadsworth/Thomson Learning: Belmont, CA.Google Scholar
Halpern, JH, Pope, HG Jr., Sherwood, AR, Barry, S, Hudson, JI, Yurgelun-Todd, D (2004). Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug and Alcohol Dependence 75, 135–147.CrossRefGoogle ScholarPubMed
Hannon, R, Adams, P, Harrington, S, Fries-Dias, C, Gipson, MT (1995). Effects of brain injury and age on prospective memory self-rating and performance. Rehabilitation Psychology 40, 289–298.CrossRefGoogle Scholar
Hoshi, R, Mullins, K, Boundy, C, Brignell, C, Piccini, P, Curran, HV (2007). Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls. Psychopharmacology 194, 371–379.CrossRefGoogle ScholarPubMed
Jacobsen, LK, Mencl, W, Pugh, KR, Skudlarski, P, Krystal, JH (2004). Preliminary evidence of hippocampal dysfunction in adolescent MDMA (‘ecstasy’) users: possible relationship to neurotoxic effects. Psychopharmacology 173, 383–390.CrossRefGoogle ScholarPubMed
Jager, G, de Win, MM, Vervaeke, HK, Schilt, T, Kahn, RS, van den Brink, W, van Ree, JM, Ramsey, NF (2007). Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study. Psychopharmacology 193, 403–414.CrossRefGoogle Scholar
Lamers, CTJ, Bechara, A, Rizzo, M, Ramaekers, JG (2006). Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. Journal of Psychopharmacology 20, 302–311.CrossRefGoogle ScholarPubMed
Lezak, MD, Howieson, DB, Loring, DW, Hannay, HJ, Fischer, JS (2004). Neuropsychological Assessment, 4th edn.Oxford University Press: New York.Google Scholar
Kalechstein, AD, De La Garza, R II, Mahoney, JJ III, Fantegrossi, WE, Newton, TF (2007). MDMA use and neurocognition: a meta-analytic review. Psychopharmacology 189, 531–537.CrossRefGoogle ScholarPubMed
McCann, UD, Eligulashvili, V, Mertl, M, Murphy, DL, Ricaurte, GA (1999). Altered neuroendocrine and behavioral m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users. Psychopharmacology 147, 56–65.CrossRefGoogle ScholarPubMed
McCann, UD, Ridenour, A, Shaham, Y, Ricaurte, GA (1994). Serotonin neurotoxicity after ±3,4-methylenedioxymethamphetamine (MDMA; ‘Ecstasy’): a controlled study in humans. Neuropsychopharmacology 10, 129–138.CrossRefGoogle ScholarPubMed
Meyers, JE, Meyers, KR (1995). Rey Complex Figure Test (RCFT) and Recognition Trial. Psychological Assessment Resources: Odessa, FL.Google Scholar
Morgan, MJ (1999). Memory deficits associated with recreational use of ‘ecstasy’ (MDMA). Psychopharmacology 141, 30–36.CrossRefGoogle ScholarPubMed
Morgan, MJ (2000). Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology 152, 230–248.CrossRefGoogle ScholarPubMed
Ozgur, O, Munir, K (2005). Attentional and neurocognitive characteristics of high-risk offspring of parents with schizophrenia compared with DSM-IV attention deficit hyperactivity disorder children. Schizophrenia Research 76, 293–299.Google Scholar
Park, SB, Coull, JT, McShane, RH, Young, AH, Sahakian, BJ, Robbins, TW, Cowen, PJ (1994). Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 33, 575–588.CrossRefGoogle ScholarPubMed
Parrott, AC, Garnham, NJ, Wesnes, K, Pincock, C (1996). Cigarette smoking and abstinence: comparative effects upon cognitive task performance and mood state over 24 hours. Human Psychopharmacology: Clinical and Experimental 11, 391–400.3.0.CO;2-Z>CrossRefGoogle Scholar
Parrott, AC, Lees, A, Garnham, NJ, Jones, M, Wesnes, K (1998). Cognitive performance in recreational users of MDMA or ‘ecstasy’: evidence for memory deficits. Journal of Psychopharmacology 12, 79–83.CrossRefGoogle ScholarPubMed
Pope, HG Jr., Gruber, AJ, Hudson, JI, Huestis, MA, Yurgelun-Todd, D (2001). Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry 58, 909–915.CrossRefGoogle ScholarPubMed
Pope, HG Jr., Yurgelun-Todd, D (2004). Residual cognitive effects of long-term cannabis use. In Marijuana and Madness: Psychiatry and Neurobiology (ed. Castle, D. and Murray, R.), pp. 198–210. Cambridge University Press: New York.CrossRefGoogle Scholar
Reneman, L, Schilt, T, De Win, MML, Booij, I, Schmand, B, Van den Brink, W, Bakker, O (2006). Memory function and serotonin transporter gene polymorphism in ecstasy (MDMA) users. Journal of Psychopharmacology 20, 389–399.CrossRefGoogle ScholarPubMed
Ricaurte, GA, Forno, LS, Wilson, MA, DeLanney, LE, Irwin, I, Molliver, ME, Langston, JW (1988). ±3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. Journal of the American Medical Association 260, 51–55.CrossRefGoogle ScholarPubMed
Riedel, WJ, Klaassen, T, Deutz, NEP, van Someren, A, van Praag, HM (1999). Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology 141, 362–369.CrossRefGoogle ScholarPubMed
Roiser, JP, Rogers, RD, Cook, LJ, Sahakian, BJ (2006). The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls. Psychopharmacology 188, 213–227.CrossRefGoogle ScholarPubMed
Roiser, JP, Rogers, RD, Sahakian, BJ (2007). Neuropsychological function in ecstasy users: a study controlling for polydrug use. Psychopharmacology 189, 505–516.CrossRefGoogle ScholarPubMed
Ruff, RM, Light, RH, Parker, SB, Levin, HS (1996). Benton Controlled Oral Word Association Test: reliability and updated norms. Archives of Clinical Neuropsychology 11, 329–338.CrossRefGoogle ScholarPubMed
Schilt, T, de Win, MML, Koeter, M, Jager, G, Korf, DJ, van den Brink, W, Schmand, B (2007). Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Archives of General Psychiatry 64, 728–736.CrossRefGoogle ScholarPubMed
Schmidt, M (1996). Rey Auditory Verbal Learning Test: A Handbook. Western Psychological Services: Los Angeles, CA.Google Scholar
Simon, NG, Mattick, RP (2002). The impact of regular ecstasy use on memory function. Addiction 97, 1523–1529.CrossRefGoogle ScholarPubMed
Spreen, O, Strauss, E (1998). A Compendium of Neuropsychological Tests: Administration, Norms and Commentary. Oxford University Press: New York.Google Scholar
Stafford, J, Degenhardt, L, Agaliotis, M, Chanteloup, F, Fischer, J, Matthews, A, Newman, J, Proudfoot, P, Stoove, M, Weekley, J (2004). Australian Trends in Ecstasy and Related Drug Markets 2004: Findings from the Party Drugs Initiative (PDI). National Drug and Alcohol Research Centre: Sydney, Australia.Google Scholar
Sumnall, HR, Tyler, E, Wagstaff, GF, Cole, JC (2004). A behavioural economic analysis of alcohol, amphetamine, cocaine and ecstasy purchases by polysubstance misusers. Drug and Alcohol Dependence 76, 93–99.CrossRefGoogle ScholarPubMed
Tabachnick, BG, Fidell, LS (2001). Using Multivariate Statistics, 4th edn.Allyn and Bacon: Boston, MA.Google Scholar
The Psychological Corporation (2001). Wechsler Test of Adult Reading (WTAR) Manual. The Psychological Corporation: San Antonio, TX.Google Scholar
Thomasius, R, Petersen, K, Buchert, R, Andresen, B, Zapletalova, P, Wartberg, L, Nebeling, B, Schmoldt, A (2003). Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology 167, 85–96.CrossRefGoogle ScholarPubMed
Thomasius, R, Zapletalova, P, Petersen, K, Buchert, R, Andresen, B, Wartberg, L, Nebeling, B, Schmoldt, A (2006). Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. Journal of Psychopharmacology 20, 211–225.CrossRefGoogle ScholarPubMed
Ward, J, Hall, K, Haslam, C (2006). Patterns of memory dysfunction in current and 2-year abstinent MDMA users. Journal of Clinical and Experimental Neuropsychology 28, 306–324.CrossRefGoogle ScholarPubMed
Wechsler, D (1997). Wechsler Adult Intelligence Scale – Third Edition. The Psychological Corporation: San Antonio, TX.Google Scholar
Wilson, BA, Alderman, N, Burgess, PW, Emslie, H, Evans, JJ (1996). Behavioural Assessment of the Dysexecutive Syndrome. Thames Valley Test Company: Bury St Edmonds, UK.Google Scholar
Wilson, BA, Cockburn, J, Baddeley, AD, Hiorns, R (1989 a). The development and validation of a test battery for detecting and monitoring everyday memory problems. Journal of Clinical and Experimental Neuropsychology 11, 855–870.CrossRefGoogle ScholarPubMed
Wilson, MA, Ricaurte, GA, Molliver, ME (1989 b). Distinct morphological classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine. Neuroscience 28, 121–137.CrossRefGoogle Scholar
Yip, J, Lee, TMC (2005). Effects of ecstasy use on neuropsychological function: a study in Hong Kong. Psychopharmacology 179, 620–628.CrossRefGoogle ScholarPubMed
Zakzanis, KK, Campbell, Z (2006). Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up. Neurology 66, 740–741.CrossRefGoogle ScholarPubMed